CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Long-term Debt and Lease Obligation in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term debt and lease obligation, classified as noncurrent.
Summary
Charles River Laboratories International, Inc. quarterly Long-term Debt and Lease Obligation history and growth rate from Q2 2010 to Q2 2024.
  • Charles River Laboratories International, Inc. Long-term Debt and Lease Obligation for the quarter ending June 29, 2024 was $2.41B, a 10% decline year-over-year.
Long-term Debt and Lease Obligation, Quarterly (USD)
Long-term Debt and Lease Obligation, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.41B -$269M -10% Jun 29, 2024 10-Q 2024-08-07
Q1 2024 $2.66B -$83.3M -3.04% Mar 30, 2024 10-Q 2024-05-09
Q4 2023 $2.65B -$60.4M -2.23% Dec 30, 2023 10-Q 2024-08-07
Q3 2023 $2.51B -$423M -14.4% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $2.68B -$319M -10.6% Jul 1, 2023 10-Q 2023-08-09
Q1 2023 $2.74B +$67.6M +2.53% Apr 1, 2023 10-Q 2023-05-11
Q4 2022 $2.71B +$44M +1.65% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $2.94B +$44.4M +1.53% Sep 24, 2022 10-Q 2022-11-02
Q2 2022 $3B +$270M +9.9% Jun 25, 2022 10-Q 2022-08-03
Q1 2022 $2.68B +$474M +21.5% Mar 26, 2022 10-Q 2022-05-04
Q4 2021 $2.66B +$734M +38% Dec 25, 2021 10-K 2023-02-22
Q3 2021 $2.89B +$925M +47% Sep 25, 2021 10-Q 2021-11-03
Q2 2021 $2.73B +$520M +23.6% Jun 26, 2021 10-Q 2021-08-04
Q1 2021 $2.2B -$124M -5.35% Mar 27, 2021 10-Q 2021-05-04
Q4 2020 $1.93B +$79.9M +4.32% Dec 26, 2020 10-K 2022-02-16
Q3 2020 $1.97B +$85.6M +4.55% Sep 26, 2020 10-Q 2020-11-09
Q2 2020 $2.21B +$167M +8.17% Jun 27, 2020 10-Q 2020-08-05
Q1 2020 $2.33B +$786M +51% Mar 28, 2020 10-Q 2020-05-07
Q4 2019 $1.85B +$239M +14.9% Dec 28, 2019 10-K 2021-02-17
Q3 2019 $1.88B +$230M +13.9% Sep 28, 2019 10-Q 2019-11-06
Q2 2019 $2.04B +$244M +13.6% Jun 29, 2019 10-Q 2019-07-31
Q1 2019 $1.54B +$411M +36.4% Mar 30, 2019 10-Q 2019-05-07
Q4 2018 $1.61B +$496M +44.5% Dec 30, 2018 10-K 2020-02-11
Q3 2018 $1.65B +$497M +43% Sep 29, 2018 10-Q 2018-11-07
Q2 2018 $1.8B +$680M +60.9% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $1.13B -$40.5M -3.46% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $1.11B -$93.6M -7.75% Dec 30, 2017 10-K 2019-02-13
Q3 2017 $1.16B -$77.2M -6.26% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $1.12B -$215M -16.1% Jul 1, 2017 10-Q 2017-08-09
Q1 2017 $1.17B +$330M +39.2% Apr 1, 2017 10-Q 2017-05-10
Q4 2016 $1.21B +$362M +42.8% Dec 31, 2016 10-K 2018-02-13
Q3 2016 $1.23B +$397M +47.5% Sep 24, 2016 10-Q 2016-11-02
Q2 2016 $1.33B +$576M +76.4% Jun 25, 2016 10-Q 2016-08-03
Q1 2016 $840M +$85.9M +11.4% Mar 26, 2016 10-Q 2016-05-04
Q4 2015 $846M +$105M +14.2% Dec 26, 2015 10-K 2017-02-14
Q3 2015 $836M +$81M +10.7% Sep 26, 2015 10-Q 2015-11-04
Q2 2015 $755M -$26.8M -3.43% Jun 27, 2015 10-Q 2015-07-30
Q1 2015 $755M +$140M +22.9% Mar 28, 2015 10-Q 2015-04-30
Q4 2014 $741M +$98.2M +15.3% Dec 27, 2014 10-K 2016-02-12
Q3 2014 $755M +$130M +20.9% Sep 27, 2014 10-Q 2014-10-30
Q2 2014 $782M +$162M +26.1% Jun 28, 2014 10-Q 2014-08-07
Q1 2014 $614M +$96.1M +18.6% Mar 29, 2014 10-Q 2014-04-30
Q4 2013 $642M +$115M +21.9% Dec 28, 2013 10-K 2015-02-17
Q3 2013 $624M +$81.2M +14.9% Sep 28, 2013 10-Q 2013-10-30
Q2 2013 $620M +$68.4M +12.4% Jun 29, 2013 10-Q 2013-07-31
Q1 2013 $518M -$157M -23.2% Mar 30, 2013 10-Q 2013-05-08
Q4 2012 $527M -$176M -25% Dec 29, 2012 10-K 2014-02-25
Q3 2012 $543M -$177M -24.6% Sep 29, 2012 10-Q 2012-11-01
Q2 2012 $551M -$180M -24.6% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $675M -$86.6M -11.4% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $703M +$32.9M +4.91% Dec 31, 2011 10-K 2013-02-27
Q3 2011 $720M +$19.4M +2.77% Sep 24, 2011 10-Q 2011-11-02
Q2 2011 $731M +$322M +78.6% Jun 25, 2011 10-Q 2011-08-03
Q1 2011 $761M Mar 26, 2011 10-Q 2011-05-04
Q4 2010 $670M Dec 25, 2010 10-K 2012-02-27
Q3 2010 $701M Sep 25, 2010 10-Q 2010-11-04
Q2 2010 $409M Jun 26, 2010 10-Q 2010-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.